FINWIRES · TerminalLIVE
FINWIRES

Oruka Therapeutics H2 ORKA-001 Data Could Further De-Risk Lead Program, UBS Says

By

Oruka Therapeutics (ORKA) could further de-risk its lead psoriasis drug candidate, ORKA-001, with H2 data expected to show stronger 28-week efficacy than its earlier results and AbbVie's (ABBV) Skyrizi, UBS Securities said in a Wednesday note.

The firm said psoriasis treatments typically show improving efficacy over time. It expects ORKA-001's PASI100 response rate to increase from about 63% at week 16 to 70% to 80% at week 28.

UBS said initial one-year durability data should provide an early indication of ORKA-001's potential for six-month or annual dosing. The firm expects the update in late Q3 or Q4, giving the company more time to include one-year data from additional patients.

The investment firm also said AbbVie's planned acquisition of Apogee Therapeutics (APGE) validates the underlying YTE platform used by ORKA-001 and eases concerns about the intellectual property landscape.

UBS maintained its buy rating on Oruka and raised its price target to $130 from $100.

Price: $94.44, Change: $-0.73, Percent Change: -0.77%

Related Articles

Wire

Resolution Minerals Completes 16 Diamond Core Holes at Idaho Prospect

Resolution Minerals (ASX:RML) said 16 diamond core holes have been drilled to planned total depths at the Golden Gate South prospect in the Horse Heaven antimony-tungsten-gold-silver project in Idaho, for a total depth of 4,470 meters, according to a Wednesday Australian bourse filing.Core logging is progressing, recording geology, alteration, and mineralization, the company said.The drilling program is planned to up to 13,700 meters in up to 45 drill holes.The company's shares were up over 2% in recent Wednesday trade.

ASX:RML
Wire

Papa John's Names Chris Collins as Interim CFO

Papa John's International (PZZA) said late Tuesday that Chris Collins, its senior vice president of corporate finance and principal accounting officer, has been appointed to take the additional role as interim chief financial officer, starting immediately.Collins succeeds Ravi Thanawala, who is exiting Papa John's to assume a CFO role at another public company. Thanawala will be available to Papa John's in an advisory capacity until July 31 to support a smooth transition, the company said.Marc Richard, the company's senior vice president of North America Operations, has assumed responsibility for all North America operations, including those overseen by Thanawala as president, according to a statement.The company said it has commenced the search for a permanent CFO.

$PZZA
Wire

Arbor Realty Trust Plans $300 Million Private Offering of Convertible Notes

Arbor Realty Trust (ABR) plans to offer $300 million of convertible senior notes due 2029 in a private placement.Initial purchasers will have a 13-day option to buy up to an additional $45 million of the notes, the company said Tuesday in a statement.Arbor Realty expects to use up to $130 million of the net proceeds to repurchase shares. It also plans to use a portion of the proceeds, along with cash on hand, to redeem its $270 million of 4.5% senior notes due Sept. 1. Any remaining proceeds will be used for general corporate purposes.Arbor Realty shares fell 3.8% in after-hours trading.

$ABR